4//SEC Filing
Yowler Jennifer 4
Accession 0000950170-24-008831
CIK 0001865782other
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 4:15 PM ET
Size
12.8 KB
Accession
0000950170-24-008831
Insider Transaction Report
Form 4
Yowler Jennifer
President, PharMerica
Transactions
- Award
Stock Options (Right to Buy)
2024-01-25+17,665→ 52,996 totalExercise: $6.37Exp: 2029-09-24→ Common Stock (17,665 underlying) - Award
Common Stock
2024-01-26+57,880→ 57,880 total - Award
Stock Options (Right to Buy)
2024-01-25+21,004→ 21,004 totalExercise: $13.00Exp: 2034-01-25→ Common Stock (21,004 underlying) - Award
Stock Options (Right to Buy)
2024-01-25+17,665→ 52,996 totalExercise: $7.01Exp: 2030-05-12→ Common Stock (17,665 underlying)
Footnotes (4)
- [F1]On January 26, 2024 reporting person was granted restricted stock units ("RSUs") which vest in three equal annual installments commencing on January 25, 2025. Each RSU represents a contingent right to receive one share of common stock upon settlement.
- [F2]Options acquired represent options originally granted on September 24, 2019, which were previously subject to the achievement by the Issuer of performance vesting criteria and which were deemed vested on January 25, 2024, in connection with the pricing of the Issuer's initial public offering. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. The remaining options are subject to a time-based vesting schedule, vesting in five equal annual installments commencing March 5, 2020. Reflects a 15.7027-for-1 forward stock split of the Issuer's common stock (the "Stock Split"), which became effective on January 25, 2024. Does not include unvested performance-based options which will be reported when earned upon achievement of certain performance criteria.
- [F3]Options acquired represent options originally granted on May 12, 2020, which were previously subject to the achievement by the Issuer of performance vesting criteria and which were deemed vested on January 25, 2024, in connection with the pricing of the Issuer's initial public offering. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. The remaining options are subject to a time-based vesting schedule, vesting in five equal annual installments commencing May 12, 2021. Reflects the Stock Split. Does not include unvested performance-based options which will be reported when earned upon achievement of certain performance criteria.
- [F4]Options granted on January 25, 2024 which vest in three equal annual installments commencing on January 25, 2025. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024.
Documents
Issuer
BrightSpring Health Services, Inc.
CIK 0001865782
Entity typeother
Related Parties
1- filerCIK 0001995316
Filing Metadata
- Form type
- 4
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 4:15 PM ET
- Size
- 12.8 KB